Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.clbc.2023.09.011

Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China

Xiaorong Zhong & Ting Luo et al. · 2023-09-19

Links

DOI PubMed

Journal

Clinical Breast Cancer

TL;DR

In the context of limited resources in China, TAM+OFS and exemestane plus OFS are cost-effective options compared with TAM.

AI-generated by Semantic Scholar

Authors

Xiaorong Zhong, Ping Chen, Ping He, Yanqi Wu, Jiaojiao Suo, Kunrui Zhu, Xi Yan, Tinglun Tian, Qing Yang, Ting Luo

Funding

Science and Technology Department of Sichuan Province Grant 20ZDYF1878 Sichuan University Funding Sichuan University West China Hospital Grant 00402053A2231 Sichuan University West China Hospital Grant 2017YFC0910004 Sichuan University West China Hospital Grant ZYGD18012 Sichuan University West China Hospital Grant ZYJC21035